(in millions, except per share data) | December 31, 2013 | December 31, 2012 | ||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 822 | $ | 1,025 | ||||
Short-term notes receivable from subsidiaries | 11 | 2,889 | ||||||
Deferred income taxes and other current assets | 214 | 225 | ||||||
Total current assets | 1,047 | 4,139 | ||||||
Equity in net assets of subsidiaries | 44,301 | 43,724 | ||||||
Long-term notes receivable from subsidiaries | 4,215 | — | ||||||
Other assets | 144 | 106 | ||||||
Total assets | $ | 49,707 | $ | 47,969 | ||||
Liabilities and shareholders’ equity | ||||||||
Current liabilities: | ||||||||
Accounts payable and accrued liabilities | $ | 335 | $ | 356 | ||||
Note payable to subsidiary | 215 | 175 | ||||||
Commercial paper and current maturities of long-term debt | 1,935 | 2,541 | ||||||
Total current liabilities | 2,485 | 3,072 | ||||||
Long-term debt, less current maturities | 14,804 | 13,602 | ||||||
Deferred income taxes and other liabilities | 269 | 117 | ||||||
Total liabilities | 17,558 | 16,791 | ||||||
Commitments and contingencies (Note 4) | ||||||||
Shareholders’ equity: | ||||||||
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding | — | — | ||||||
Common stock, $0.01 par value - 3,000 shares authorized; 988 and 1,019 issued and outstanding | 10 | 10 | ||||||
Additional paid-in capital | — | 66 | ||||||
Retained earnings | 33,047 | 30,664 | ||||||
Accumulated other comprehensive (loss) income | (908 | ) | 438 | |||||
Total UnitedHealth Group shareholders’ equity | 32,149 | 31,178 | ||||||
Total liabilities and shareholders’ equity | $ | 49,707 | $ | 47,969 | ||||